
|Articles|December 10, 2007
New trials may cut clopidogrel use
A trio of late-breaking clinical trials could change standard drug treatment for patients undergoing percutaneous coronary intervention, or PCI.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
3
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
4
Pharmacists Want Prescribing Authority With Proper Training, Support
5






























